Über uns
Dr. Ali Chamseddine is a Consultant Medical Oncologist from France, holding dual board certifications in medical oncology and clinical haematology, as well as MD and PhD degrees. He gained expertise at the esteemed Gustave Roussy Cancer Center in Villejuif, France, where he served as a senior medical oncology consultant. Dr. Chamseddine further honed his skills through a post-doctoral fellowship at the Division of Cancer Medicine, Leukaemia Department, at the renowned MD Anderson Cancer Center in Houston, Texas, USA.
Throughout his career, Dr. Chamseddine has been deeply involved in research, with over 50 publications in prestigious journals, including the New England Journal of Medicine. Dr. Chamseddine's clinical expertise spans various areas of oncology, with a primary focus on Precision Oncology, Gastrointestinal Tumours, Breast and Genitourinary Tumours, and Lung Cancer.
He is an active member of esteemed professional organisations such as the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), and the European Hematology Association (EHA), among others.
Dr. Chamseddine's specific areas of interest include gastrointestinal cancers, breast cancer, genitourinary cancers, lung cancer, gynecologic cancers, central nervous system cancers, and soft-tissue sarcomas. He is also deeply committed to palliative and supportive care in cancer patients. Dr. Chamseddine focuses on developing patient-centric and personalised treatment approaches, identifying predictive markers for better benefit-risk balance of anticancer drugs, and implementing liquid biopsy for improved molecular characterization of cancers.
Throughout his career, Dr. Chamseddine has been deeply involved in research, with over 50 publications in prestigious journals, including the New England Journal of Medicine. Dr. Chamseddine's clinical expertise spans various areas of oncology, with a primary focus on Precision Oncology, Gastrointestinal Tumours, Breast and Genitourinary Tumours, and Lung Cancer.
He is an active member of esteemed professional organisations such as the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), and the European Hematology Association (EHA), among others.
Dr. Chamseddine's specific areas of interest include gastrointestinal cancers, breast cancer, genitourinary cancers, lung cancer, gynecologic cancers, central nervous system cancers, and soft-tissue sarcomas. He is also deeply committed to palliative and supportive care in cancer patients. Dr. Chamseddine focuses on developing patient-centric and personalised treatment approaches, identifying predictive markers for better benefit-risk balance of anticancer drugs, and implementing liquid biopsy for improved molecular characterization of cancers.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr. Ali Chamseddine
Ausbildung & Training
-
2007–2013 MD · Medicine and Surgery
-
2013–2017 Residency · Onkologie
Karriere & Anstellungen
-
2017-09–2018-08 Junior consultant
Lizenzen & Versicherung
Medizinische Lizenzen
AE — Organización Médica Colegial de España (OMC)
Facharztzertifikate
European Board of Onkologie
Berufshaftpflichtversicherung:
Allianz Professional · 5,000,000 EUR Deckung · No claims on file
Durchgeführte Verfahren
| Verfahren | Code | Lebenszeit-Anzahl |
|---|---|---|
| GP consultation | 99213 | 130 |
| Annual physical exam | 99395 | 2,884 |
| Vaccination administration | 90471 | 1,828 |
| Minor procedure (skin) | 17110 | 1,267 |
Leistungen & Preise
| Leistung | Dauer | Modalität | Preis |
|---|---|---|---|
| New patient consultation (60m) | 60 Min. | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 Min. | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 Min. | in_clinic | 270.00 EUR |
| Minor procedure (skin) | 120 Min. | in_clinic | 360.00 EUR |
Praxis, Team & in der Praxis
Videos
Forschung & Publikationen
h-Index: 11 · i10: 3
-
Validation of clinical scoring in Onkologie
DOI: 10.7129/euroclin.2026.0 · PMID: 37579667 · zitiert von 130
-
Long-term follow-up of Onkologie across AE
DOI: 10.5594/euroclin.2025.1 · PMID: 31987343 · zitiert von 200
-
Validation of clinical scoring in Onkologie
DOI: 10.6633/euroclin.2024.2 · PMID: 37865520 · zitiert von 118
Eingeladene Vorträge
- Practical updates in Onkologie European Annual Congress (Onkologie) · Vienna · 2024 · invited
- Single-centre experience in Onkologie National Society Meeting · Dubai · 2023 · oral abstract
Auszeichnungen & Mitgliedschaften
Auszeichnungen
- 🏆 Top-rated Onkologie — Dubai · EuroClinics Patient Choice · 2025 · regional
Gesellschaftsmitgliedschaften
- WONCA Europe — Family Doctors — Member · Seit 2018
- national college of family doctors — Member · Seit 2018
- European Union of Medical Specialists (UEMS) — Member · Seit 2018
Artikel dieses Arztes
- Patient education Patient guide to Onkologie
- Awareness When should you see a onkologie?
Für internationale Patienten
- Koordinator
- Patient liaison · ali.chamseddine@euroclinics.example
Standort
1 TagPatientenbewertungen
Teilen Sie Ihre Erfahrung — Helfen Sie anderen Patienten, den richtigen Arzt zu finden. Bewertung schreiben →
Aktuelle Bewertungen
-
★★★★★ ✓ Verifiziert Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verifiziert Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verifiziert Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
Ähnliche Spezialisten
Alle durchsuchen →
Dr Susan Jane Mincham
Onkologie · Murdoch
Dr Serena Bee Neo Sia
Onkologie · Murdoch
Dr Rohen White
Onkologie · Wembley
Dr Tee Sin Lim
Onkologie · Wembley
Dr Nadine Beydoun
Onkologie · Kogarah
Dr Muhammad Alamgeer
Onkologie · Mornington
Dr Mohammed Islam
Onkologie · Smithfield
Dr Desmond Yip
Onkologie · Garran